Biodesix seeks to raise up to $79M in IPO
BOULDER — Lung cancer testing company Biodesix Inc. is seeking to raise as much as $79 million in its initial […]
Source: BizWest
Related Articles
BizWest celebrates 40 years covering business and recognizes 40 iconic leaders who inspired the region’s development.
View related stories: Click here to view the 40th Anniversary supplement. ‘Turnpike’ helps define how economy has changed Wood: Preserving…
Biodesix expects significant sales growth in third quarter
BOULDER — Biodesix Inc. (Nasdaq: BDSX), a Boulder-headquartered life-sciences company that specializes in developing tools to detect lung disease, is…
Biodesix losses grow with pivot from COVID-19 testing
BOULDER — Biodesix Inc. (Nasdaq: BDSX), a life-sciences company that specializes in developing tools to detect lung disease, saw its…
Biodesix offers new shares to bolster credit line
BOULDER — Biodesix Inc. (Nasdaq: BDSX), a life-sciences company that specializes in developing tools to detect lung disease, has launched…
Boulder biotech firm Biodesix leases former Kohl’s store in Louisville
LOUISVILLE — Cancer diagnostics and khaki shorts. The pair of words doesn’t really fit together in any meaningful context —…